Cerebral near infrared spectroscopy for the measurement of indocyanine green elimination in cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 7, 2000, Pages 923-928

  Therapondos, G ^a   Plevris, J N ^a   Stanley, A J ^a   Peters, C J ^a   Teig, M ^a   Hayes, P C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG CLEARANCE; HUMAN; INFRARED SPECTROMETRY; LIVER CIRRHOSIS; PRIORITY JOURNAL; VALIDATION PROCESS;

COLORING AGENTS; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; METABOLIC CLEARANCE RATE; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, INFRARED;

EID: 0033922504     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00789.x     Document Type: Article

References (15)

1. 1 Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol 1958; 99: 11.
2. 2 Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay and hepatic extraction. J Clin Invest 1960; 39: 592-600.
3. 3 Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43-57.
4. 4 Hopton P, Philips B, Walsh T, et al. Non-invasive measurement of indocyanine green (ICG) elimination using cerebral near infrared spectroscopy (NIRS). Gut 1996; 38(Suppl. 1):
5. 5 Gilmore IT, Marigold JH, Thompson RPH. Half-life time or clearance of indocyanine green in patients with liver disease. Hepato-Gastroenterol 1982; 29: 55-7.
6. 6 Jalan R, Plevris JN, Jalan AR, Finlayson NDC, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994; 58: 196-200.
7. 7 Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatol 1996; 24: 1165-71.
8. 8 Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatol 1991; 14: 1029-34.
9. 9 Koneru B, Leevy CB, Klein KM, Zweil P. Clearance of indocyanine green in the evaluation of liver donors. Transplantation 1994; 58: 729-31.
10. 10 Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine Green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163: 515-8.
11. 11 Kholoussy AM, Pollack D, Matsumoto T. Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med 1984; 12: 115-6.
12. 12 Ishigami Y, Masuzawa M, Miyoshi E, et al. Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol 1993; 19: 232-40.
13. 13 Shimizu S, Kamiike W, Hatanaka N, et al. New method for measuring ICG Rmax with a clearance meter. World J Surg 1995; 19: 113-8.
14. 14 Henthorn T, Avram M, Krejcie T. Intravascular mixing and drug distribution: The concurrent disposition of thiopental and indocyanine green. Clin Pharmacol Ther 1989; 45: 56-65.
15. 15 Barbare JC, Poupon RE, Jaillon P, Prod'homme S, Darnis F, Poupon RY. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis. J Hepatol 1985; 1: 253-9.